Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3823866 | 0.80 | HIF1A (0.31) | — | |
| SCHEMBL31710677 | 0.73 | SPHK1 (0.33) | SPHK2SPHK1 | |
| SCHEMBL22470846 | 0.69 | — | — | |
| SCHEMBL9446255 | 0.67 | SCD (0.38) | — | |
| SCHEMBL2212384 | 0.64 | EPHX1 (0.37) | — | |
| SCHEMBL11807343 | 0.59 | CYP1A2 (0.37) | — | |
| SCHEMBL4839413 | 0.59 | CYP1A2 (0.39) | SPHK1 | |
| SCHEMBL13900594 | 0.58 | CYP1A2 (0.44) | — | |
| SCHEMBL113288 | 0.58 | CYP1A2 (0.44) | — | |
| SCHEMBL23352536 | 0.58 | NPC1 (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024033944-A1 | FRAGRANCE COMPOSITION AND METHODS THEREOF | DABUR INDIA LIMITED (IN) | 2024-02-15 | — | — | WO | claimed |
| US-11390797-B2 | Compositions to improve, optimize, or maximize proppant suspension and methods of making and using same | NEXTIER COMPLETION SOLUTIONS INC. (US) | 2022-07-19 | — | — | US | claimed |
| CN-110179172-B | Consumable for an aerosol-generating device | 菲利普莫里斯生产公司 | 2022-06-24 | — | — | CN | claimed |
| US-20200354627-A1 | COMPOSITIONS TO IMPROVE, OPTIMIZE, OR MAXIMIZE PROPPANT SUSPENSION AND METHODS OF MAKING AND USING SAME | NEXTIER COMPLETION SOLUTIONS INC. (US) | 2020-11-12 | — | — | US | claimed |
| EP-1767185-B2 | Core shell capsules containing an oil or waxy solid | TAKASAGO PERFUMERY CO LTD (JP) | 2018-11-28 | — | — | EP | claimed |
| EP-1767185-B1 | Core shell capsules containing an oil or waxy solid | TAKASAGO PERFUMERY CO LTD (JP) | 2010-10-27 | — | — | EP | claimed |
| US-20070149424-A1 | Perfume for capsule composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-06-28 | — | — | US | claimed |
| EP-1767185-A1 | Core shell capsules containing an oil or waxy solid | Takasago International Corporation (JP) | 2007-03-28 | — | — | EP | claimed |
| US-20260077021-A1 | Compositions and Methods for Treating Endocrine Diseases and Disorders | OLFACTIVE AL INC (US) | 2026-03-19 | — | — | US | disclosed |
| US-20250295623-A1 | Compositions and Methods for Treating Hypertension by Modulating Endocrine Activity | OLFACTIVE AI, INC. | 2025-09-25 | — | — | US | disclosed |
| US-20250213657-A1 | Compositions and Methods for Treating Neurodegenerative Diseases and Disorders | OLFACTIVE AI, INC. | 2025-07-03 | — | — | US | disclosed |
| US-20250213656-A1 | Compositions and Methods for Treating Cardiovascular Diseases and Disorders | OLFACTIVE AI, INC. | 2025-07-03 | — | — | US | disclosed |
| US-12290550-B1 | Compositions and methods for treating endocrine diseases and disorders | OLFACTIVE AI, INC. (US) | 2025-05-06 | — | — | US | disclosed |
| US-12186299-B1 | Compositions and methods for treating hypertension by modulating endocrine activity | Olfactive Biosolutions, LLC (US) | 2025-01-07 | — | — | US | disclosed |
| US-20050119156-A1 | Aromachemicals | FLEXITRAL, INC. | 2005-06-02 | — | — | US | disclosed |
| US-20050096852-A1 | Method for increasing the stability and intensity of odorant molecules | FLEXITRAL, INC. | 2005-05-05 | — | — | US | disclosed |
| WO-2004092182-A1 | FRAGRANCE COMPOSITIONS COMPRISING BENZO[4,5]THIENO[3,2-B]PYRAN-2-ONE | FLEXITRAL, INC. (US) | 2004-10-28 | — | — | WO | disclosed |
| EP-1458666-A1 | IMPROVED AROMACHEMICALS | Flexitral Inc. (US) | 2004-09-22 | — | — | EP | disclosed |
| WO-2003053887-A1 | A METHOD FOR INCREASING THE STABILITY AND INTENSITY OF ODORANT MOLECULES | FLEXITRAL, INC. (US) | 2003-07-03 | — | — | WO | disclosed |
| WO-2003053902-A1 | IMPROVED AROMACHEMICALS | FLEXITRAL, INC. (US) | 2003-07-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260077021-A1 | Compositions and Methods for Treating Endocrine Diseases and Disorders | GLP1R, GIPR, FFAR2 | SPHK2 1643/4885SPHK1 1750/4885 |
| US-20050096852-A1 | Method for increasing the stability and intensity of odorant molecules | OR51E2, OR10J3, ZKSCAN2 | SPHK2 1901/4885SPHK1 2420/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.